Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Wave Life Sci Ord Sh (WVE)

$8.63 0.25 (2.98%)

15:31 EST WVE Stock Quote Delayed 15 Minutes

Volume:

Previous Close $8.38

Market Cap 239.57M

PE Ratio -

EPS -

Volume (Avg. Vol.) 261,208

Day's Range 8.35 - 8.75

52-Week Range 6.89 - 48.64

Dividend & Yield N/A (N/A)

WVE Stock Predictions, Articles, and Wave Life Sci Ord Sh News

From InvestorPlace
From the Web

Wave Life Sciences News: WVE Stock Crashes 50% on Huntington’s Disease Data

By William White, InvestorPlace Writer Dec 30, 2019

Wave Life Sciences (WVE) news for Monday has WVE stock taking a beating on early data from its Huntington’s disease trial.

Wave Life Sciences News: WVE Stock Slammed 54% by Duchenne Drug Failure

By William White, InvestorPlace Writer Dec 16, 2019

Wave Life Sciences (WVE) news for Monday about it giving up on a Duchenne muscular dystrophy drug is hitting WVE stock hard.

The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data

From Benzinga Feb 5, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 4) Acceleron Pharma Inc (...

The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO

From Benzinga Jan 31, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 30) Acceleron Pharma Inc (...

Is Wave Life Sciences Ltd.’s (NASDAQ:WVE) CEO Overpaid Relative To Its Peers?

From Simply Wall St Jan 16, 2020

Paul Bolno has been the CEO of Wave Life Sciences Ltd. (NASDAQ:WVE) since 2013. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-wve/wave-life-sciences/news/is-wave-life-sciences-ltd-s-nasdaqwve-ceo-overpaid-relative-to-its-peers/">Read More...</a></div>

Wave Life Sciences Enters Oversold Territory

From Zacks Investment Research Jan 16, 2020

Wave Life Sciences Ltd. (WVE) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Wave Life Sciences Enters Oversold Territory

From Zacks Investment Research Jan 14, 2020

Wave Life Sciences Ltd. (WVE) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Stock Market Rally Continues Into 2020; Tesla, Lockheed Soar, Incyte Plunges: Weekly Review

From Investor's Business Daily Jan 3, 2020

The stock market rally capped a strong 2019 and kept going in 2020. Tesla stock and Lockheed Martin were big winners. Incyte was among biotech losers.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

D

Sell